OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment - press release - 2nd study

Second study in Obstetrics & Gynecology showcases OVA1's role in evaluating women with an ovarian mass

 "In the manuscript "Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors," physician assessment and the use of OVA1 correctly identified 70% of malignancies missed by physician assessment among gynecologists and other non-gynecologic oncologists, and 95% of malignancies missed by physician assessment among gynecologic oncologists. OVA1 also detected 76% of malignancies that would have been missed by CA 125 using ACOG-recommended guidelines......"